1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Barrett Esophagus

1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with Barrett Esophagus in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Beer, DG; Behar, J; Cao, W; Chin, YE; Lambeth, D; Si, J; Wands, J	1

Other Studies

1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Barrett Esophagus

Article	Year
STAT5 mediates PAF-induced NADPH oxidase NOX5-S expression in Barrett's esophageal adenocarcinoma cells. American journal of physiology. Gastrointestinal and liver physiology, 2008, Volume: 294, Issue:1 Topics: Adenocarcinoma; Arachidonic Acids; Barrett Esophagus; Cell Line, Tumor; Enzyme Inhibitors; Esophageal Neoplasms; Flavonoids; Humans; Hydrogen Peroxide; Hydrogen-Ion Concentration; MAP Kinase Kinase 1; Membrane Proteins; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; NADPH Oxidase 5; NADPH Oxidases; Phospholipases A2, Cytosolic; Phospholipid Ethers; Phosphorylation; Platelet Activating Factor; Platelet Aggregation Inhibitors; Promoter Regions, Genetic; RNA Interference; RNA, Small Interfering; Signal Transduction; STAT5 Transcription Factor; Transfection; Up-Regulation	2008

Article

Year

STAT5 mediates PAF-induced NADPH oxidase NOX5-S expression in Barrett's esophageal adenocarcinoma cells.

American journal of physiology. Gastrointestinal and liver physiology, 2008, Volume: 294, Issue:1

Topics: Adenocarcinoma; Arachidonic Acids; Barrett Esophagus; Cell Line, Tumor; Enzyme Inhibitors; Esophageal Neoplasms; Flavonoids; Humans; Hydrogen Peroxide; Hydrogen-Ion Concentration; MAP Kinase Kinase 1; Membrane Proteins; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; NADPH Oxidase 5; NADPH Oxidases; Phospholipases A2, Cytosolic; Phospholipid Ethers; Phosphorylation; Platelet Activating Factor; Platelet Aggregation Inhibitors; Promoter Regions, Genetic; RNA Interference; RNA, Small Interfering; Signal Transduction; STAT5 Transcription Factor; Transfection; Up-Regulation

2008